The Foreign Investment Promotion Board (FIPB), headed by Finance Secretary Arvind Mayaram, is scheduled to meet on July 4, the Finance Ministry said.
As per the FIPB agenda, Johnson and Johnson, Koye Pharmaceutical and Kemin Industries South Asia are among the nine FDI proposals related to pharmaceutical sector.
Also Read
While India allows FDI in most of the sectors through automatic route, foreign investments in certain sectors, like defence and pharmaceuticals, have to be first approved by the FIPB.
Foreign investments are crucial for India which needs about USD 1 trillion by March 2017 to overhaul infrastructure such as ports, airports and highways and boost growth.
The decline in foreign investments could affect the country's balance of payments and the rupee value.
Overall FDI into India grew by 8 per cent year-on-year to USD 24.3 billion in 2013-14.
The FDI into India has declined 26 per cent to USD 1.70 billion in April - the lowest in last five months.
Overall, the inflows had aggregated to USD 24.29 billion in 2013-14 as against USD 22.42 billion in 2012-13.
In 2013-14, Singapore replaced Mauritius as the top source of FDI into India, accounting for about 25 per cent of total inflows.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)